Envestnet Asset Management
TRIB

Envestnet Asset Management’s Trinity Biotech TRIB Stock Holding History

Envestnet Asset Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,620
Closed -$56.5K – 4082
2023
Q1 		$56.5K Sell
10,620
-9,471
-47% -$48.8K ﹤0.01% 3841
2022
Q4 		$99.5K Hold
20,091
– – ﹤0.01% 3816
2022
Q3 		$108K Buy
20,091
+478
+2% +$3.08K ﹤0.01% 3723
2022
Q2 		$120K Hold
19,613
– – ﹤0.01% 3738
2022
Q1 		$104K Sell
19,613
-2,567
-12% -$14.8K ﹤0.01% 3798
2021
Q4 		$159K Buy
+22,180
New +$210K ﹤0.01% 3697
2015
Q1 		– Sell
-128
Closed -$11K – 2389
2014
Q4 		$11K Sell
128
-170
-57% -$14.7K ﹤0.01% 1941
2014
Q3 		$27K Sell
298
-40
-12% -$4.33K ﹤0.01% 1762
2014
Q2 		$39K Sell
338
-1
-0.3% -$119 ﹤0.01% 1534
2014
Q1 		$41K Buy
339
+12
+4% +$1.57K ﹤0.01% 1429
2013
Q4 		$41K Buy
327
+59
+22% +$7.08K ﹤0.01% 1281
2013
Q3 		$29K Buy
+268
New +$26.1K ﹤0.01% 1365

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
AC
Aristides Capital Louisville, Kentucky $462M AUM 28.94% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return

Envestnet Asset Management's TRIB Position: Q2 2023 in Review

Envestnet Asset Management sold out of Trinity Biotech (TRIB) in Q2 2023, closing a stake of 10,620 shares — an estimated $56.5K sold.

Envestnet Asset Management first reported a position in TRIB in Q3 2013 and held it in 12 quarters. The position peaked at $159K in Q4 2021. 20 funds tracked by Wall St. Rank hold TRIB as of Q2 2023.

  • Envestnet Asset Management reported no remaining Trinity Biotech position as of Q2 2023 after selling out during the quarter.
  • Envestnet Asset Management sold 10,620 Trinity Biotech shares in Q2 2023, an estimated $56.5K.
  • Envestnet Asset Management first reported a position in Trinity Biotech in Q3 2013 and held it in 12 quarters.
  • Envestnet Asset Management's Trinity Biotech position peaked at $159K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2023.

Based on Envestnet Asset Management's 13F filing for Q2 2023, filed 4 Aug 2023.